BIOPHARMASPEC — 2180894
Application number
2180894
Registration number
TMA1293148
International Registration Number
1222354
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2022-04-06
International Registration
2014-04-22
Registered
2025-02-24
Registration Expiry Date
2034-04-22
Registered Owner
Biopharmaspec Limited
Beachside Business Centre,
Rue Du Hocq,
St Clement
JERSEY JE2 6LF
JERSEY
Agent
MARKS & CLERK
33 Yonge Street,
Suite 300
Toronto
ONTARIO M5E1G4
Documents
Index headings
- BIOPHARMASPEC
- BIO PHARMA SPEC
Services (Nice class & Statement)
- 41
- (1) Educational, training and instructional services in the nature of courses, seminars, tutorials, conferences and workshops in the field of biopharmaceutical scientific research and analysis; providing education and training services, namely, training courses, seminars, tutorials, conferences and workshops on scientific analysis and analytical techniques in the analysis of biopharmaceuticals; production of sound and video recordings in the field of scientific research and analysis for training purposes; publication of training manuals and educational, instructional and teaching materials; publication of scientific reports and texts; providing online electronic publications, namely, electronic books and journals in the field of scientific research and analysis; information, advisory and consultancy services relating to all of the aforesaid services
- 42
- (2) Scientific research in the fields of chemistry and biochemistry; biopharmaceutical research and development; scientific analytical services, namely, chemical and biochemical analysis services for scientific research purposes; development of scientific analytical methods in the field of chemistry and biochemistry based on mass spectrometry and chromatography; pharmaceutical, biopharmaceutical and biotechnological discovery, research and development services; pharmacokinetics research and development services; preclinical analytical testing services in the field of chemistry and biochemistry, namely testing of biopharmaceuticals; laboratory research and services in the field of pharmaceuticals, biochemistry and chemistry for analytical testing; bacteria testing and analysis services; biopharmaceutical sample testing and analysis services in the field of chemistry and biochemistry for scientific research and analysis; mass spectrometry services; chromatography services; protein and glycoprotein analysis and sequencing; carbohydrate analysis and sequencing; gas phase sequencing; DNA, RNA and Protein analysis services for scientific research purposes; SEC MALLS analysis [Size Exclusion Chromatography (SEC) with Multi-Angle Laser-Light Scattering-protein aggregation analysis]; amino acid and sugar composition analysis; analysis of aggregates in biopharmaceutical samples in the field of chemistry and biochemistry for scientific research and analysis; structural characterisation of biopolymers, small molecule drugs and metabolites; compilation and provision of mass spectrometric, chromatographic and biophysical data in the field of chemistry and biochemistry research and analysis; scientific data interpretation services, namely, scientific analysis in the field of chemistry and biochemistry; preparation and provision of scientific reports, namely, providing scientific information in the fields of chemistry and biochemistry; provision of certificates of analysis, namely for the purposes of certifying the results of scientific analysis in the field of chemistry and biochemistry; design of computer software or computer programs for scientific or analytical applications; providing automated use of on-line non-downloadable software for automated presentation and interpretation of mass spectrometric and chromatographic data for scientific and medical research; information, advisory and consultancy services relating to all of the aforesaid services
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| International Registration | 2014-04-22 | 2024-04-22 | |
| Filed | 2022-04-06 | Subsequent designation | |
| Designation Notification - Madrid Protocol | 2022-04-21 | 2023-10-21 | |
| Created | 2022-04-21 | ||
| Formalized | 2022-04-21 | ||
| Notification of Possible Opposition Sent | 2023-02-21 | ||
| Search Recorded | 2023-08-08 | ||
| Examiner's First Report | 2023-08-08 | 2024-02-08 | |
| Total Provisional Refusal | 2023-08-08 | 2024-02-08 | |
| IR Renewed | 2024-04-22 | 2034-04-22 | DP:2024-02-22 |
| Agent Changed | 2024-10-15 | From: To: 119 | |
| Approved | 2024-11-06 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2024-11-06 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2024-12-04 | Vol.71 Issue 3658 | |
| Opposition Start Date Notice Sent | 2024-12-04 | Requested on 2024/12/04 00:30:12 in program jr500m1 | |
| Registration Pending | 2025-02-24 | ||
| Registered | 2025-02-24 | ||
| Statement of Grant of Protection Sent (following a Provisional Refusal) | 2025-02-24 | ||
| Agent Changed | 2025-06-12 | From: 119 To: 3272 |